Company news

Genvor Incorporated news in 2026

Genvor Incorporated's news releases, calls and decks from 2026, newest first.

View company

Genvor’s Antimicrobial Peptides Advance into Sugar Beet Research

July 27, 2026

Genvor Appoints Donald Kalkofen as Chief Financial Officer

May 21, 2026

Genvor Announces Strategic Memorandum of Understanding with Canlab International(TM) to Advance Peptide Pipeline

April 17, 2026

Genvor Announces Strategic Memorandum of Understanding with Canlab International™ to Advance Commercial Peptide Pipeline

April 14, 2026

Genvor to Present at Centri Capital Conference on April 14

April 7, 2026

Genvor, Inc. Presenting at NIBA's 152nd Investment Conference in Fort Lauderdale, FL March 12, 2026

March 5, 2026

Genvor Announces Strategic Expansion into Health and Wellness Market, Leveraging Proprietary AI-Accelerated BioCypher Platform to Develop Consumer Peptide Solutions

March 4, 2026

Genvor’s AGM182 Antifungal Peptide Technology Validated in Peer-Reviewed Publication in PhytoFrontiers™

February 11, 2026

Genvor Appoints Dr. George Stavrides as Executive Vice President, Business Development & Commercialization

January 28, 2026

DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event

January 23, 2026

Genvor, Inc. to Present at the 3rd Annual DealFlow Discovery Conference

January 20, 2026

Decks in 2026